Yale University

Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.

TitleAssociations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
Publication TypeJournal Article
Year of Publication2017
AuthorsDubrow, Robert, Li Qin, Haiqun Lin, Raúl U. Hernández-Ramírez, Romain S. Neugebauer, Wendy Leyden, Keri N. Althoff, Chad J. Achenbach, Nancy A. Hessol, Sharada P. Modur, Gypsyamber D'Souza, Ronald J. Bosch, Surbhi Grover, Michael A. Horberg, Mari M. Kitahata, Angel M. Mayor, Richard M. Novak, Charles S. Rabkin, Timothy R. Sterling, James J. Goedert, Amy C. Justice, Eric A. Engels, Richard D. Moore, and Michael J. Silverberg
Corporate AuthorsNorth American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS
JournalJournal of acquired immune deficiency syndromes (1999)
Date Published2017 Apr 07
ISSN1944-7884
AbstractKaposi sarcoma (KS) remains common among HIV-infected persons. To better understand KS etiology and to help target prevention efforts, we comprehensively examined a variety of CD4+ T-cell count and HIV-1 RNA viral load (VL) measures, as well as antiretroviral therapy (ART) use, to determine independent predictors of KS risk.
DOI10.1097/QAI.0000000000001394
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links